Martindale Pharma extends distribution deal with AAH Pharmaceuticals

Martindale Pharma has extended its agreement for the exclusive distribution of hospital products with AAH Pharmaceuticals.

AAH is to continue as the supplier of Martindale Pharma's products to NHS and private hospitals in England for a further three years, while Martindale will continue to use AAH for distribution of its hospital products in Scotland alongside TPS and in Northern Ireland alongside United Drug Sangers.

Michael Harris, chief executive officer of Martindale Pharma, said: "We were impressed with AAH's partnership approach to working with us and believe that this new three-year agreement will continue to improve our supply chain."

The firm also announced that it has been awarded more than 20 products in response to a tender from the Department of Health for a new supply of medicines that will be used to maintain the Essential Medicines Buffer Stockpile over the next four years.

Consisting of essential medicines routinely used in the NHS, the stockpile is available for release into the UK supply chain in the event of a pandemic or some other health emergency.

Martindale Pharma will supply emergency care medicines, as well as important treatments for opioid dependency. The value of these products is approximately 3.6 million pounds.